Valeant Interim CEO to Testify Before Congress

Howard Schiller, interim CEO of Valeant Pharmaceuticals, is planning to testify at a congressional hearing next week that will explore drug-price increases.

from WSJ.com: US Business http://ift.tt/1Nl9udY
via IFTTT